Logo image of SMID

SMITH-MIDLAND CORP (SMID) Stock Fundamental Analysis

NASDAQ:SMID - Nasdaq - US8321561032 - Common Stock - Currency: USD

38  -0.26 (-0.68%)

Fundamental Rating

5

Taking everything into account, SMID scores 5 out of 10 in our fundamental rating. SMID was compared to 13 industry peers in the Construction Materials industry. SMID has only an average score on both its financial health and profitability. SMID is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SMID had positive earnings in the past year.
SMID had a positive operating cash flow in the past year.
In the past 5 years SMID has always been profitable.
SMID had a positive operating cash flow in 4 of the past 5 years.
SMID Yearly Net Income VS EBIT VS OCF VS FCFSMID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

With a decent Return On Assets value of 11.29%, SMID is doing good in the industry, outperforming 76.92% of the companies in the same industry.
Looking at the Return On Equity, with a value of 18.39%, SMID is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
The Return On Invested Capital of SMID (12.92%) is better than 76.92% of its industry peers.
SMID had an Average Return On Invested Capital over the past 3 years of 5.33%. This is significantly below the industry average of 10.74%.
The last Return On Invested Capital (12.92%) for SMID is above the 3 year average (5.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.29%
ROE 18.39%
ROIC 12.92%
ROA(3y)4.69%
ROA(5y)6.8%
ROE(3y)7.71%
ROE(5y)11.65%
ROIC(3y)5.33%
ROIC(5y)6.74%
SMID Yearly ROA, ROE, ROICSMID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 9.78%, SMID perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
In the last couple of years the Profit Margin of SMID has grown nicely.
The Operating Margin of SMID (12.61%) is worse than 61.54% of its industry peers.
SMID's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 25.49%, SMID is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SMID has grown nicely.
Industry RankSector Rank
OM 12.61%
PM (TTM) 9.78%
GM 25.49%
OM growth 3Y1.15%
OM growth 5Y18.21%
PM growth 3Y-13.2%
PM growth 5Y18.54%
GM growth 3Y-3.63%
GM growth 5Y3.6%
SMID Yearly Profit, Operating, Gross MarginsSMID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

6

2. Health

2.1 Basic Checks

SMID has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SMID remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SMID has more shares outstanding
SMID has a better debt/assets ratio than last year.
SMID Yearly Shares OutstandingSMID Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
SMID Yearly Total Debt VS Total AssetsSMID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

SMID has an Altman-Z score of 7.31. This indicates that SMID is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SMID (7.31) is better than 92.31% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that SMID is not too dependend on debt financing.
SMID has a Debt to Equity ratio of 0.11. This is in the better half of the industry: SMID outperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 7.31
ROIC/WACC1.25
WACC10.33%
SMID Yearly LT Debt VS Equity VS FCFSMID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

SMID has a Current Ratio of 2.39. This indicates that SMID is financially healthy and has no problem in meeting its short term obligations.
SMID's Current ratio of 2.39 is fine compared to the rest of the industry. SMID outperforms 69.23% of its industry peers.
SMID has a Quick Ratio of 1.94. This is a normal value and indicates that SMID is financially healthy and should not expect problems in meeting its short term obligations.
SMID has a Quick ratio of 1.94. This is amongst the best in the industry. SMID outperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.94
SMID Yearly Current Assets VS Current LiabilitesSMID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 840.52% over the past year.
SMID shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.73% yearly.
The Revenue has grown by 31.77% in the past year. This is a very strong growth!
The Revenue has been growing by 10.95% on average over the past years. This is quite good.
EPS 1Y (TTM)840.52%
EPS 3Y0.03%
EPS 5Y30.73%
EPS Q2Q%505.06%
Revenue 1Y (TTM)31.77%
Revenue growth 3Y15.74%
Revenue growth 5Y10.95%
Sales Q2Q%12.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SMID Yearly Revenue VS EstimatesSMID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.39, the valuation of SMID can be described as expensive.
SMID's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.51. SMID is around the same levels.
Industry RankSector Rank
PE 26.39
Fwd PE N/A
SMID Price Earnings VS Forward Price EarningsSMID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

SMID's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.84
SMID Per share dataSMID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

SMID has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.86
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SMID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SMITH-MIDLAND CORP

NASDAQ:SMID (7/14/2025, 8:05:08 PM)

38

-0.26 (-0.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)07-01 2025-07-01
Earnings (Next)08-12 2025-08-12
Inst Owners60.92%
Inst Owner Change0%
Ins Owners3.89%
Ins Owner Change0%
Market Cap201.40M
Analysts0
Price TargetN/A
Short Float %4.06%
Short Ratio11.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.39
Fwd PE N/A
P/S 2.57
P/FCF N/A
P/OCF 39.05
P/B 4.83
P/tB 4.83
EV/EBITDA 15.84
EPS(TTM)1.44
EY3.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.97
OCFY2.56%
SpS14.81
BVpS7.88
TBVpS7.88
PEG (NY)N/A
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 11.29%
ROE 18.39%
ROCE 18.68%
ROIC 12.92%
ROICexc 15.06%
ROICexgc 15.06%
OM 12.61%
PM (TTM) 9.78%
GM 25.49%
FCFM N/A
ROA(3y)4.69%
ROA(5y)6.8%
ROE(3y)7.71%
ROE(5y)11.65%
ROIC(3y)5.33%
ROIC(5y)6.74%
ROICexc(3y)6.27%
ROICexc(5y)8.94%
ROICexgc(3y)6.27%
ROICexgc(5y)8.94%
ROCE(3y)7.71%
ROCE(5y)9.76%
ROICexcg growth 3Y-2.89%
ROICexcg growth 5Y20.7%
ROICexc growth 3Y-2.89%
ROICexc growth 5Y20.7%
OM growth 3Y1.15%
OM growth 5Y18.21%
PM growth 3Y-13.2%
PM growth 5Y18.54%
GM growth 3Y-3.63%
GM growth 5Y3.6%
F-Score7
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 0.35
Cap/Depr 232.85%
Cap/Sales 7.9%
Interest Coverage 44.39
Cash Conversion 41.06%
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 1.94
Altman-Z 7.31
F-Score7
WACC10.33%
ROIC/WACC1.25
Cap/Depr(3y)179.06%
Cap/Depr(5y)169.48%
Cap/Sales(3y)7.27%
Cap/Sales(5y)7.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)840.52%
EPS 3Y0.03%
EPS 5Y30.73%
EPS Q2Q%505.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.77%
Revenue growth 3Y15.74%
Revenue growth 5Y10.95%
Sales Q2Q%12.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y790.11%
EBIT growth 3Y17.07%
EBIT growth 5Y31.16%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-138.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.29%
OCF growth 3Y-17.33%
OCF growth 5Y5.59%